Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

NCT01090167

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Nagoya Daini Red Cross Hospital Aichi, Japan
  • National Hospital Organization Nagoya Medical Center Aichi, Japan
  • University of Fukui Hospital Fukui, Japan
  • Tokai University Hospital Kanagawa, Japan
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Completed

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

NCT01256073

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Institut Paoli-Calmettes Marseille, Marseille Cedex 09, France
  • Hopital Dupuytren Limoges, France
  • C.H.R.U. de Nantes - Hotel Dieu Nantes, France
  • Centre Hospitalier Lyon Sud - Hospices Civils de Lyon Pierre-Bénite, France
View Trial Details
Completed

STI571 in Treating Patients With Recurrent Leukemia

NCT00004932

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 235 locations
View Trial Details
Completed

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View all 16 locations
View Trial Details

Related conditions